Health Care -

Your samples

  • No items in the basket
  • Add more products View basket View products to order samples

Remove from basket

Are you sure you want to remove from the sample cart?

Your Language

English Português Español
Health Care
Health Care
  • Products and Applications
    • Product Finder
    • Dietary Supplements  
    • Eye, Ear & Nose  
    • Vaccine Adjuvants  
    • Omega 3 API  
    • Oral  
    • Parenteral  
    • Rectal and Vaginal  
    • Topical  
    • Veterinary Health  
      • Formulation Finder

        Formulation Finder

        Browse our range of fully developed formulations for inspiration and guidance.
        View
  • Technical Library
    • Formulation Finder
    • Brochures  
    • Datasheets and MSDS  
    • FDA IID Sheets  
    • Vaccine Adjuvants – Certificates of GMP Compliance  
    • Excipient Information Package  
    • Presentations  
    • Product Overview Sheets  
    • Videos  
    • Webinars  
      • Product Finder

        Product Finder

        Find a product to suit your needs from our high purity excipients portfolio.
        Product Finder
  • Discovery Zone
    • Product Effects
      • SEDDS and SMEDDS  
      • Increased Vaccine Efficacy  
      • Solubilisers and Emulsifiers  
      • Solvents  
      • Penetration Enhancers  
      • Controlled Release  
      • Skin Barrier Repair with Lanolin  
      • Film Forming Polymers  
    • Chemical Industry Helping to Fight COVID-19  
    • Our Technologies
      • Super Refined Excipients  
      • API grade Omega 3  
      • Vaccine Adjuvant Technology  
      • New Drug Delivery Technology – ProSilic®  
    • Emulsifier Selector  
    • Pharmaceutical Solubility Guide  
    • Veterinary Solubility Guide  
    • Leaders in Regulatory Excellence  
    • How We Can Help  
    • Events Calendar
      • Smarter Innovation Through Quality  
      • DDF Summit - March 2021  
      • Product Effects

        Product Effects

        View our product offerings.
        View
  • News
    • Business News  
    • Events  
    • Innovation  
    • Sustainability  
    • Trends  
      • Events Calendar

        Events Calendar

        We will be present at key industry events taking place over the year around the globe.
        Events
  • Contact  
  1. Home
  2. News
  3. 2019
  4. 01
  5. Acquisition of Market Leading Vaccine Adjuvant Specialist

News categories

  • Business News
  • Events
  • Innovation
  • Sustainability
  • Trends

Acquisition of Market Leading Vaccine Adjuvant Specialist

Innovation, Business News
2 Jan 2019

Croda International Plc, the speciality chemical company that creates high performance ingredients and technologies relied upon by industry and consumers globally, today announced that it has strengthened its pharmaceutical offering by acquiring Brenntag Biosector (Biosector), for a total consideration of €72 million in cash. 

Founded in 1939, Biosector has unprecedented industry experience as a vaccine adjuvant specialist, with their product portfolio comprising of innovative aluminium- and saponin-based adjuvants. The Biosector team, based in Frederikssund, Denmark will be welcomed to the Croda group and continue to be led by Managing Director Peter Tygesen.

Vaccine adjuvants are a complimentary extension of Croda’s existing pharmaceutical excipients portfolio within their Health Care business. The acquisition of Biosector will give Croda access to an industry renowned product portfolio of adjuvants, including the well-known brands Alhydrogel® and Adju-Phos®, as well as their technically advanced saponin-based adjuvant systems. Through this acquisition, Croda will not only gain ownership to Biosector’s rich development pipeline for second and third generation adjuvant platforms but will also become the only adjuvant supplier in the world with an aseptic and GMP certified manufacturing site for vaccine adjuvants. 

Croda will leverage its own dedicated global sales network to accelerate Biosector’s growth. Furthermore, the acquisition will enable Croda to better support their existing customers through increased breadth of offering and additional technical expertise in vaccine adjuvants.

Nick Challoner, President of Life Sciences at Croda comments:

“Biosector is a rare asset in a high-value, fast-growing sector of the global pharmaceutical market. With an experienced team, Biosector brings world-class innovation and industry-leading manufacturing facilities. The opportunity to quickly build upon Biosector’s impressive track record via our global sales network is enormously exciting and we look forward to welcoming the team to Croda.”  

Peter Tygesen, Managing Director Biosector, said:

“Croda share our passion for exciting innovation. Under the Croda umbrella we look forward to continuing to grow and further establish our research and development into high quality industry-leading adjuvant platforms.”

For more information, please use our online contact form.

Share this page

  • Click to print this page
  • LinkedIn
  • Facebook
  • Click to share this page on twitter
  • Click to email
    Email Address
    Are you human?
Product Finder Search our product database
MSDS Search for a material safety datasheet
Contact Us Contact your local office

Health Care

We at Croda contribute to a healthier world by offering ingredients and formulation expertise which help our pharmaceutical customers get the best performance from their active ingredients.

Follow us on social media
  • Health Care on LinkedIn

Corporate

  • Products and markets
  • Where we operate
  • Current vacancies
  • Annual Report
  • Sustainability Reports
  • GRI Report
Visit our corporate site
© 2021 Croda International Plc
© 2021 Croda International Plc | Terms and Conditions | Privacy Policy | Accessibility statement

About cookies on this site
By continuing to use this website, you agree to the use of cookies. You can find out more details in our Privacy policy.